"Osteomalacia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
| Descriptor ID |
D010018
|
| MeSH Number(s) |
C05.116.198.816.640 C18.452.104.816.640 C18.452.174.845.640 C18.654.521.500.133.770.734.640
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Osteomalacia".
Below are MeSH descriptors whose meaning is more specific than "Osteomalacia".
This graph shows the total number of publications written about "Osteomalacia" by people in this website by year, and whether "Osteomalacia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteomalacia" by people in Profiles.
-
Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap. Head Neck. 2019 06; 41(6):E93-E98.
-
Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions. J Pediatr Hematol Oncol. 2017 01; 39(1):e21-e24.
-
Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis. Head Neck Pathol. 2016 Sep; 10(3):279-85.
-
Severe hypophosphatemia in a 79-year-old man. Clin Chem. 2014 Jul; 60(7):928-31.
-
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 2014 Jan 15; 23(2):397-407.
-
Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series. Ann Diagn Pathol. 2013 Aug; 17(4):319-21.
-
Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract. 2008 Dec; 14(9):1108-14.
-
Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab. 2007 Jun; 92(6):2374-7.
-
Frequency of osteomalacia in elderly patients with hip fractures. J Pak Med Assoc. 2006 Jun; 56(6):273-6.
-
A pathologic fracture: underestimated mechanism in a patient with risk factors. J Emerg Med. 2004 Feb; 26(2):207-8.